<p>RAGE expression was studied on CD4+ or CD8+ T cells before and 48 hrs after culture with anti-CD3 mAb. RAGE expression was higher on CD4+ (p<0.001) and CD8+ (p<0.001) T cells from patients with T1D vs healthy controls. While the level of RAGE expression increased in CD4+ and CD8+ T cells from healthy control subjects (p<0.05), it decreased in the patients with T1D (p<0.05).</p
Type 1 diabetes is an autoimmune disease with no cure, where clinical translation of promising thera...
Type 1 diabetes (T1DM) is an autoimmune disorder resulting in destruction of the insulin producing p...
The receptor for advanced glycation end products (RAGE) is a novel protein increasingly studied in t...
<p>A:PBMC were isolated from patients with T1D (top two rows) and T2D (bottom row). They were staine...
The Receptor for Advanced Glycation Endproducts (RAGE) is a scavenger ligand that binds glycated end...
<p>Peripheral blood cells were cultured with or without EBV peptide and IL-2 with or without S100b. ...
<p>A: The phenotype of RAGE+ and − PBMC from patients with T1D were studied by flow cytometry (n = 4...
<p>A: Surface RAGE expression was studied on CD11c+ PBMC before (top) and after (bottom) culture wit...
<p>Peripheral blood cells from HLA-A2.1+ healthy control subjects that were cultured with or without...
The receptor for glycation end products (RAGE) has been previously implicated in shaping the adaptiv...
Type 1 diabetes (T1D) is one of the most common chronic diseases manifesting in early life, with the...
Background. Severe traumatization induces a complex pathophysiology, driven by the patient’s own imm...
The receptor for advanced glycation endproducts (RAGE) functions as part of an innate immune signali...
Diabetes is associated with increased glucose levels and accumulation of glycated products. It is al...
<p>Representative immunoblots for RAGE, TGF-β1, Col I and III (a) and the corresponding densitometry...
Type 1 diabetes is an autoimmune disease with no cure, where clinical translation of promising thera...
Type 1 diabetes (T1DM) is an autoimmune disorder resulting in destruction of the insulin producing p...
The receptor for advanced glycation end products (RAGE) is a novel protein increasingly studied in t...
<p>A:PBMC were isolated from patients with T1D (top two rows) and T2D (bottom row). They were staine...
The Receptor for Advanced Glycation Endproducts (RAGE) is a scavenger ligand that binds glycated end...
<p>Peripheral blood cells were cultured with or without EBV peptide and IL-2 with or without S100b. ...
<p>A: The phenotype of RAGE+ and − PBMC from patients with T1D were studied by flow cytometry (n = 4...
<p>A: Surface RAGE expression was studied on CD11c+ PBMC before (top) and after (bottom) culture wit...
<p>Peripheral blood cells from HLA-A2.1+ healthy control subjects that were cultured with or without...
The receptor for glycation end products (RAGE) has been previously implicated in shaping the adaptiv...
Type 1 diabetes (T1D) is one of the most common chronic diseases manifesting in early life, with the...
Background. Severe traumatization induces a complex pathophysiology, driven by the patient’s own imm...
The receptor for advanced glycation endproducts (RAGE) functions as part of an innate immune signali...
Diabetes is associated with increased glucose levels and accumulation of glycated products. It is al...
<p>Representative immunoblots for RAGE, TGF-β1, Col I and III (a) and the corresponding densitometry...
Type 1 diabetes is an autoimmune disease with no cure, where clinical translation of promising thera...
Type 1 diabetes (T1DM) is an autoimmune disorder resulting in destruction of the insulin producing p...
The receptor for advanced glycation end products (RAGE) is a novel protein increasingly studied in t...